menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

AP
Medical science liaisons provide a bridge between drug development and external stakeholders, meaning they are in an ideal situation to capture valuable scientific insights.
Forrest Anthony
FDA unanimously recommends approving this gene altering therapy for pediatric lymphoblastic leukemia.
Read More
Andy Tisman
How wellness trends and emerging markets growth are boosting sales in over-the-counter products.
Read More
Ray Huml
With patent expirations looming, biologic companies must innovate – or litigate – to protect their market share.
Read More
Sarah Rickwood
What it takes to thrive in an increasingly specialized marketplace.
Read More
Olga Uspenskaya-Cadoz
Tau imaging and predictive analytics take center stage at the annual event held by the Alzheimer’s Association.
Read More
Deep Patel
The growing need to treat and prevent AD is spurring new research, but healthcare industry stakeholders need to work collaboratively if we are going to successfully bring groundbreaking treatments to market.
Read More
Alison Bourke
QuintilesIMS Research Forum showcases groundbreaking studies using RWD that are aiding public policy decisions and treatment protocols.
Read More
Lisa Marie Saldanha
This is the first in a series of blogs about new models to improve collaborative academic research efficiency and increase its probability of success.
Read More
Susan Abedi
Ray Huml